During the past decade, IRCCS Istituto Clinico Humanitas; Oncologia conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "IRCCS Istituto Clinico Humanitas; Oncologia" #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Associazione Italiana di Immunogenetica e Biologia dei Trapianti (AIBT)" with 1 trials as a collaborator, "Azienda Policlinico Umberto I" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "IRCCS Istituto Clinico Humanitas; Oncologia" are "Breast Cancer" (2 trials), "Hematologic Diseases" (2 trials), "Metastatic Colorectal Cancer" (2 trials), "Triple-Negative Breast Cancer" (2 trials) and "Acute Myeloblastic Leukemia" (1 trials). Many other conditions were trialed in "IRCCS Istituto Clinico Humanitas; Oncologia" in a lesser frequency.

Most popular intervention types in "IRCCS Istituto Clinico Humanitas; Oncologia" are "Drug" (13 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Paclitaxel" (3 trials), "Carboplatin" (2 trials), "Placebo" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "IRCCS Istituto Clinico Humanitas; Oncologia" are 17 trials for "All" genders.

Currently, there are NaN active trials in "IRCCS Istituto Clinico Humanitas; Oncologia". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in IRCCS Istituto Clinico Humanitas; Oncologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in IRCCS Istituto Clinico Humanitas; Oncologia, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".